Acute Lymphoblastic Leukemia Pediatric

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-03-10
Clinical Trial Update: CD-19 CAR-T Cell for Pediatric ALL or Lymphoma [NA]
Clinical trial update for a CD-19 CAR-T cell therapy being investigated for pediatric acute lymphoblastic leukemia and pediatric lymphoma; t…
CLINICAL_TRIALS trial_result · 2025-02-18
Clinical Trial Update: A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL [Phase 2]
A Phase 2 prospective, open-label, randomized, multicenter trial evaluating matched-sibling donor hematopoietic stem cell transplantation us…
CLINICAL_TRIALS research · 2024-11-12
Clinical Trial Update: Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells [Phase 1, Phase 2]
An ongoing Phase 1/2 clinical trial evaluating sequential CD5/CD7-specific CAR-T cells for CD5/CD7-positive T-cell malignancies including T-…
CLINICAL_TRIALS trial_result · 2024-01-08
Clinical Trial Update: Safety and Efficacy of Curcumin in Children With Acute Lymphoblastic Leukemia [Phase 2]
A Phase 2 clinical trial evaluating safety and efficacy of curcumin in pediatric acute lymphoblastic leukemia has been completed.
CLINICAL_TRIALS trial_result · 2020-01-14
Clinical Trial Update: The Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in China [Phase 2, Phase 3]
A pediatric trial evaluating individualized 6-mercaptopurine treatment for acute lymphoblastic leukemia in China across Phase 2 and Phase 3.
Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
CLINICAL_TRIALS trial_result · 2017-01-30
Clinical Trial Update: Study of the Intermediate Metabolism in Children With Acute Lymphoblastic Leukemia (ALL)
A clinical trial investigating intermediate metabolism in children with acute lymphoblastic leukemia; the current status is unknown.